Loading...
Flucloxacillin — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Flucloxacillin
2025-Q4
Comprehensive analysis of India’s flucloxacillin export trade — suppliers, buyers, prices, routes, and every shipment record.
153
Shipments
$4.52M
Trade Value
32
Suppliers
27
Buyers
25
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/flucloxacillin
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s flucloxacillin trade — 2025-Q4
KEY TAKEAWAY
Flucloxacillin 2025-Q4 exports total $4.5M across 25 countries, with MICRO LABS LTD commanding 39.7% market share.
TOTAL SHIPMENTS
153
2025-Q4
EXPORT VALUE
$4.5M
FOB USD
TOTAL QUANTITY
52.5M
units shipped
INDIAN SUPPLIERS
32
unique exporters
GLOBAL BUYERS
27
unique importers
DESTINATIONS
25
countries
MEDIAN UNIT PRICE
$0.151
per unit
TOP-5 SHARE
87.8%
of total USD
BRANDED SHARE
35.3%
54 shipments
DOSAGE FORMS
7
product types
6 KEY FINDINGS
1
MICRO LABS LTD is India's #1 Flucloxacillin exporter with $1.8M (39.7% market share).→ §5, Indian Supplier Rankings
2
Flucloxacillin reached 25 countries, with United Kingdom as the top destination ($2.3M).→ §4, Global Destination Map
3
Market concentration is high (HHI: 2572) — top 10 suppliers control 96.5% of exports.→ §5, Indian Supplier Rankings
4
92.6% of buyers (25 of 27) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Capsule dominates (74.4%) across 7 dosage forms.→ §7, Price Benchmarks
6
24 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 MICRO LABS LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian flucloxacillin exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Flucloxacillin report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial flucloxacillin trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian flucloxacillin suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Flucloxacillin India trade report
Product scope
Flucloxacillin
All variants merged — branded and generic formulations of flucloxacillin
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
153
Every commercial flucloxacillin trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $1.5M, Nov $1.9M, Dec $1.1M. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$1.5M
Oct USD
51 shipments
2
$1.9M
Nov USD
+27.5% MoM
3
$1.1M
Dec USD
-43.4% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 27.5% in USD but shipment count kept steady.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $1.5M, making it the middle month by value.
Fig 3.2 Q4 cumulative USD reached $4.5M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $415K rise in Nov, $835K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $1.5M | 51 shipments |
| Nov | $1.9M | 49 shipments |
| Dec | $1.1M | 53 shipments |
| Q4 Total | $4.5M | 153 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: United Kingdom held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: MEDREICH LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import flucloxacillin from India, how much they buy, and who supplies each market
KEY TAKEAWAY
United Kingdom absorbs 51.6% of India’s 2025-Q4 flucloxacillin trade ($2.3M). Beyond the top 10 destinations, 24 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 11 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 24 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much flucloxacillin India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$8K
0.2% of trade
3 countries · 4 shipments
Europe
$3.4M
74.6% of trade
5 countries · 71 shipments
Africa
$391K
8.6% of trade
11 countries · 38 shipments
Oceania
$749K
16.6% of trade
6 countries · 40 shipments
Fig 4.1 United Kingdom is the #1 corridor ($2.3M) — 25 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian flucloxacillin it receives (light = low, dark = high). Orange arcs radiate from India to the top 25 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | United Kingdom | $2.3M | 45 | MICRO LABS LTD | $1.8M | MEDREICH LTD | $538K | — | — |
| 2 | Sweden | $730K | 10 | CADILA PHARMACEUTICALS LTD | $730K | — | — | — | — |
| 3 | New Zealand | $304K | 5 | MEDREICH LTD | $304K | — | — | — | — |
| 4 | Papua New Guinea | $254K | 27 | MAXMED LIFE SCIENCES PVT LTD | $137K | SPARSH BIO-TECH PVT LTD | $73K | ARIHANT EXPORTERS | $39K |
| 5 | Australia | $183K | 3 | MEDREICH LTD | $183K | — | — | — | — |
| 6 | Kenya | $175K | 11 | INNOVA CAPTAB LTD | $75K | LAXMI PHARMACEUTICALS PVT LTD | $52K | SPARSH BIO-TECH PVT LTD | $37K |
| 7 | Netherlands | $139K | 7 | MEDREICH LTD | $139K | — | — | — | — |
| 8 | South Africa | $118K | 9 | KOPRAN LTD | $85K | MEDREICH LTD | $32K | SARTHI PHARMA | $868 |
| 9 | Finland | $85K | 2 | AUROBINDO PHARMA LTD | $85K | — | — | — | — |
| 10 | France | $84K | 7 | AJANTA PHARMA LTD | $84K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 0.2% of USD — but United Kingdom is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
51.6%
#1 country share
United Kingdom alone
84.2%
Top 5 share
5 of 25 countries
99.7%
Top 15 share
Long tail of 10 countries = 0.3%
HHI 3061
Destination HHI
Highly concentrated
25
Countries served
Global pharma reach from India
11
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
32 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
MICRO LABS LTD ($1.8M, 39.7% share) and MEDREICH LTD ($1.2M) together control 66.2% of India’s 2025-Q4 flucloxacillin trade. The top 5 suppliers hold 87.8%. 32 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian flucloxacillin suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 MICRO LABS LTD leads by $602K over MEDREICH LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: AUROBINDO PHARMA LTD is #7 by value but #15 by volume.
Fig 5.2 MICRO LABS LTD also leads by shipment count (40) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: AUROBINDO PHARMA LTD moves from #15 by volume to #7 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 32 flucloxacillin suppliers split into strategic segments
KEY TAKEAWAY
8 suppliers (25%) generate 93.4% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 MICRO LABS LTD and MEDREICH LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 93.4% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | AJANTA PHARMA LTD | 3 | 1 | $84K |
| 2 | SCOTT EDIL PHARMACIA LTD | 3 | 2 | $19K |
| 3 | FINDLIFE PHARMACEUTICAL | 3 | 2 | $9K |
| 4 | MEDREICH LTD | 2 | 5 | $1.2M |
| 5 | SPARSH BIO-TECH PVT LTD | 2 | 2 | $110K |
| 6 | NIMESH PHARMA | 2 | 1 | $65K |
| 7 | ARIHANT EXPORTERS | 2 | 1 | $39K |
| 8 | MEDOPHARM PVT LTD | 2 | 1 | $10K |
| 9 | WHITE LOTUS HEALTHCARE | 2 | 1 | $3K |
| 10 | LEVINS PHARMADEALS INTERNATIONAL (OPC) PRIVATE LI | 2 | 1 | $2K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the flucloxacillin manufacturing hubs
KEY TAKEAWAY
Bangalore and Bengaluru together account for $2.7M of India’s 2025-Q4 flucloxacillin trade.
Fig 5.5 Bangalore (1 exporters, $1.6M) and Bengaluru (1 exporters, $1.0M) are India’s flucloxacillin capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
87.8%
Top 5 share
5 of 32 suppliers
96.5%
Top 10 share
10 of 32 suppliers
93.4%
Top 25% share
8 suppliers = 93% USD
HHI 2572
Supplier HHI
Concentrated
32
Total suppliers
shipped Flucloxacillin in 2025-Q4
20+ cities
Indian hubs
Bangalore and Bengaluru lead
§5.2 Coming next: 2 exporter deep-dive profiles
Each of the top 2 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | MEDREICH LTD | $1.2M |
| #2 | SPARSH BIO-TECH PVT LTD | $110K |
#2
EXPORTER PROFILE #1 OF 2
MEDREICH LTD
Bengaluru · India’s #2 flucloxacillin supplier by USD · 2025-Q4
2025-Q4 USD
$1.2M
26.4% market share
SHIPMENTS
21
avg $57K/ship
COUNTRIES
5
destination markets
BUYERS
6
5 single-sourced
BRANDED
76%
of shipments
DOSAGE FORMS
2
product types
TOP 5 DESTINATIONS
United Kingdom is the #1 market at $538K (45% of trade), followed by New Zealand at $304K. 5 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | United Kingdom | $538K | 5 | 45.0% |
| 2 | New Zealand | $304K | 5 | 25.4% |
| 3 | Australia | $183K | 3 | 15.3% |
| 4 | Netherlands | $139K | 7 | 11.6% |
| 5 | South Africa | $32K | 1 | 2.7% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $585K.
PRODUCT MIX
Capsule dominates at 88% of trade. Tablet (11.6%) and others are secondary formulations.
TOP BUYERS · 5/5 LOCKED IN
5 of 5 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| MEDREICH PLC | United Kingdom | $538K | ⚠ Locked |
| VIATRIS NEW ZEALAND | New Zealand | $214K | ⚠ Locked |
| Undisclosed buyer | New Zealand | $150K | N/A |
| MYLAN IRELAND LTD | Netherlands | $139K | ⚠ Locked |
| MYLAN AUSTRALIA PTY LTD | Australia | $122K | ⚠ Locked |
| SANDOZSA(PTY)LTD | South Africa | $32K | ⚠ Locked |
#2
EXPORTER PROFILE #1 OF 2 — TRADE FLOW MAP
MEDREICH LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P1.3 United Kingdom absorbs $538K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
#5
EXPORTER PROFILE #2 OF 2
SPARSH BIO-TECH PVT LTD
Jamnagar · India’s #5 flucloxacillin supplier by USD · 2025-Q4
2025-Q4 USD
$110K
2.4% market share
SHIPMENTS
6
avg $18K/ship
COUNTRIES
2
destination markets
BUYERS
3
1 single-sourced
BRANDED
0%
of shipments
DOSAGE FORMS
2
product types
TOP 2 DESTINATIONS
Papua New Guinea is the #1 market at $73K (66% of trade), followed by Kenya at $37K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Papua New Guinea | $73K | 2 | 66.5% |
| 2 | Kenya | $37K | 4 | 33.5% |
MONTHLY TREND
Oct peaked at $98K. Dec was the weakest at $0.
PRODUCT MIX
Capsule dominates at 66% of trade. Solution (33.5%) and others are secondary formulations.
TOP BUYERS · 1/1 LOCKED IN
1 of 1 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Papua New Guinea | $73K | N/A |
| SPARSH BIO-TECH HEALTH… | Kenya | $31K | ⚠ Locked |
| Undisclosed buyer | Kenya | $6K | N/A |
#5
EXPORTER PROFILE #2 OF 2 — TRADE FLOW MAP
SPARSH BIO-TECH PVT LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P2.3 Papua New Guinea absorbs $73K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
27 importers across 25 countries — who is buying Indian flucloxacillin and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 84.3% of total USD. 93% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian flucloxacillin. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 BROWN AND BURK UK LTD is the #1 importer at $1.6M (36.3%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
93%
Single-source
25 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
7%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source flucloxacillin from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Kenya 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| CROWN SOLUTIONS LTD | INNOVA CAPTAB LTD | $75K | $3.759 | Capsule |
| CROWN HEALTHCARE | LAXMI PHARMACEUTICAL… | $52K | $0.130 | Injection |
| SPARSH BIO-TECH HEALTH… | SPARSH BIO-TECH PVT … | $31K | $20.840 | Solution |
Papua New Guinea 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SESAGO HEALTH CARE LTD | ARIHANT EXPORTERS | $39K | $0.268 | Capsule |
| GANNET PHARMA LTD | LEVINS PHARMADEALS I… | $979.409 | $19.588 | Capsule |
| INDENT & PHARMACEUTICALS | LEVINS PHARMADEALS I… | $878.841 | $0.879 | Injection |
United Kingdom 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| BROWN AND BURK UK LTD | MICRO LABS LTD | $1.6M | $0.062 | Capsule |
| MEDREICH PLC | MEDREICH LTD | $538K | $0.055 | Capsule |
Sweden 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| EQL PHARMA | CADILA PHARMACEUTICA… | $730K | $0.271 | Tablet |
New Zealand 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| VIATRIS NEW ZEALAND | MEDREICH LTD | $214K | $0.067 | Capsule |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | BROWN AND BURK UK LTD | United Kingdom | $1.6M | $43K | Premium |
| 2 | EQL PHARMA | Sweden | $730K | $73K | Premium |
| 3 | MEDREICH PLC | United Kingdom | $538K | $108K | Premium |
| 4 | VIATRIS NEW ZEALAND | New Zealand | $214K | $71K | Premium |
| 5 | MYLAN IRELAND LTD | Netherlands | $139K | $20K | Mid |
| 6 | MYLAN AUSTRALIA PTY … | Australia | $122K | $61K | Premium |
| 7 | ORION CORP | Finland | $85K | $43K | Premium |
| 8 | PLANET PHARMA SA | France | $84K | $12K | Budget |
| 9 | CROWN SOLUTIONS LTD | Kenya | $75K | $19K | Mid |
| 10 | CROWN HEALTHCARE | Kenya | $52K | $26K | Mid |
| 11 | SESAGO HEALTH CARE LTD | Papua New Guinea | $39K | $4K | Budget |
| 12 | SANDOZSA(PTY)LTD | South Africa | $32K | $32K | Mid |
| 13 | SPARSH BIO-TECH HEAL… | Kenya | $31K | $10K | Budget |
| 14 | LOTUS PHARMA | Burundi | $10K | $5K | Budget |
| 15 | ACE HEALTH CARE LDA | Mozambique | $8K | $8K | Budget |
| 16 | PHARMA STAR | Gambia | $5K | $5K | Budget |
| 17 | STATE BANK OF MAURIT… | Mauritius | $2K | $927.000 | Budget |
| 18 | GANNET PHARMA LTD | Papua New Guinea | $979.409 | $979.000 | Budget |
| 19 | CONTINENTAL PHARMACE… | Malawi | $919.223 | $919.000 | Budget |
| 20 | INDENT & PHARMACEUTI… | Papua New Guinea | $878.841 | $439.000 | Budget |
| 21 | T. CHOITHRAM & SONS | Sierra Leone | $825.349 | $413.000 | Budget |
| 22 | REPUBLIC OF NAURU - … | Nauru | $410.176 | $205.000 | Budget |
| 23 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | $274.365 | $274.000 | Budget |
| 24 | TOTHE ORDER SHARJAH … | Angola | $200.458 | $200.000 | Budget |
| 25 | QUADRI MEDICAL PTY LTD | Lesotho | $47.791 | $48.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 MICRO LABS LTD → BROWN AND BURK UK LTD is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian flucloxacillin prices vary by supplier, country and dosage form
KEY TAKEAWAY
Flucloxacillin prices span 2708036× ($0.0001 → $357.54). The coefficient of variation is 5.05. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0001 | Lowest observed unit price |
| P5 | $0.0001 | 5th percentile |
| P25 | $0.062 | 25th percentile (Q1) |
| Median | $0.151 | 50th percentile (Q2) |
| P75 | $2.00 | 75th percentile (Q3) |
| P95 | $20.96 | 95th percentile |
| Max | $357.54 | Highest observed unit price |
| Mean | $6.19 | Arithmetic average |
| CV | 505% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 SCOTT EDIL PHARMACIA LTD prices at $130.96/unit vs market median $0.151.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. MICRO LABS LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. MAXMED LIFE SCIENCES Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. AUROBINDO PHARMA LTD Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. GIRISH ENTERPRISES Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | KOPRAN LTD | South Africa | Capsule | 156 | $83K | $533.31 | Specialty / small-batch |
| Oct 2025 | SCOTT EDIL PHARM… | Kenya | Solution | 30 | $11K | $357.54 | Specialty / small-batch |
| Oct 2025 | SPARSH BIO-TECH … | Papua New Guinea | Capsule | 363 | $26K | $72.82 | Specialty / small-batch |
| Oct 2025 | SPARSH BIO-TECH … | Papua New Guinea | Capsule | 696 | $47K | $67.52 | Specialty / small-batch |
| Dec 2025 | WHITE LOTUS HEAL… | Papua New Guinea | Other | 49 | $3K | $57.11 | Specialty / small-batch |
| Dec 2025 | WHITE LOTUS HEAL… | Papua New Guinea | Other | 1 | $39.72 | $39.72 | Specialty / small-batch |
| Dec 2025 | SCOTT EDIL PHARM… | Myanmar | Capsule | 50 | $2K | $34.88 | Specialty / small-batch |
| Dec 2025 | SEATRACK INTERNA… | United Arab Emirates | Capsule | 10 | $274.36 | $27.44 | Specialty / small-batch |
| Nov 2025 | SPARSH BIO-TECH … | Kenya | Solution | 296 | $6K | $20.96 | Specialty / small-batch |
| Nov 2025 | SPARSH BIO-TECH … | Kenya | Solution | 296 | $6K | $20.96 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | ARIHANT EXPORTERS | Papua New Guinea | Injection | 400 | $0.957 | $0.0024 | Sterile formulation premium |
| Dec 2025 | ARIHANT EXPORTERS | Papua New Guinea | Injection | 23K | $55.49 | $0.0024 | Sterile formulation premium |
| Dec 2025 | ARIHANT EXPORTERS | Papua New Guinea | Injection | 24K | $71.07 | $0.0030 | Sterile formulation premium |
| Dec 2025 | KAMAL INTERNATIO… | Papua New Guinea | Injection | 300 | $1.23 | $0.0041 | Sterile formulation premium |
| Dec 2025 | HLL LIFECARE LTD | Nauru | Injection | 2K | $36.88 | $0.020 | Sterile formulation premium |
| Dec 2025 | HLL LIFECARE LTD | Nauru | Capsule | 18K | $373.30 | $0.020 | |
| Dec 2025 | AJANTA PHARMA LTD | France | Capsule | 8K | $192.87 | $0.024 | |
| Dec 2025 | MEDREICH LTD | South Africa | Capsule | 852K | $32K | $0.037 | |
| Oct 2025 | MEDI SCHWALL PHA… | Lesotho | Tablet | 1K | $47.79 | $0.048 | |
| Nov 2025 | MEDREICH LTD | United Kingdom | Capsule | 1.5M | $78K | $0.054 | Bulk volume discount |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship flucloxacillin, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Flucloxacillin leaves India through 15+ ports. The top 5 (BANGALORE ICD, ENNORE SEA, MUNDRA SEA) handle 83.3% of total USD. SEA moves 63% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 BANGALORE ICD handles $1.1M — top 15 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 LONDON GATWAY PORT is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 63% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$2.7M
59.4% of USD · 63.4% of ships
ICD
$1.5M
33.1% of USD · 20.3% of ships
AIR
$338K
7.5% of USD · 16.3% of ships
Fig 8.3 The dominant corridor is ENNORE SEA → Sea → Europe ($942K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Sweden is the most concentrated destination (HHI 10000, 1 suppliers). Kenya is the most competitive (HHI 3211).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Sweden (HHI 10,000) is the most concentrated — Kenya (HHI 3,211) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| BROWN AND BURK UK LTD | United Kingdom | MICRO LABS LTD | $1.6M | 38 | CRITICAL |
| EQL PHARMA | Sweden | CADILA PHARMACEU… | $730K | 10 | CRITICAL |
| MEDREICH PLC | United Kingdom | MEDREICH LTD | $538K | 5 | CRITICAL |
| VIATRIS NEW ZEALAND | New Zealand | MEDREICH LTD | $214K | 3 | HIGH |
| MYLAN IRELAND LTD | Netherlands | MEDREICH LTD | $139K | 7 | HIGH |
| MYLAN AUSTRALIA PTY … | Australia | MEDREICH LTD | $122K | 2 | HIGH |
| ORION CORP | Finland | AUROBINDO PHARMA… | $85K | 2 | MEDIUM |
| PLANET PHARMA SA | France | AJANTA PHARMA LTD | $84K | 7 | MEDIUM |
Conclusion: 25 buyers depend on exactly one Indian supplier, representing $3.8M in trade. 3 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| United Kingdom | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Sweden | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| New Zealand | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Papua New Guinea | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Australia | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Netherlands | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| South Africa | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Finland | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| France | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Ghana | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Gambia | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Burundi | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Mozambique | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Myanmar | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in United Kingdom | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Sweden lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter United Kingdom (2 suppliers) | This Q | HIGH |
| A6 | Enter Sweden (1 suppliers) | This Q | MED |
| A8 | Build Sweden distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (MEDREICH LTD) | This Q | MED |
| A7 | Register for United Kingdom tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | United Kingdom | Other | 2 | $2.3M | -68.3% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Sweden | Other | 1 | $730K | -27.8% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | New Zealand | Other | 1 | $304K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Australia | Other | 1 | $183K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Kenya | Africa | 4 | $175K | -100% | LOW | Low competition (4 suppliers), accessible market |
| 6 | Netherlands | Other | 1 | $139K | -4% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | South Africa | Africa | 4 | $118K | 0% | LOW | Low competition (4 suppliers), accessible market |
| 8 | Finland | Other | 1 | $85K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | France | Other | 1 | $84K | -42.5% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Ghana | Africa | 2 | $66K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Gambia | Africa | 1 | $10K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Burundi | Africa | 1 | $10K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Mozambique | Africa | 1 | $8K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Myanmar | Asia | 1 | $8K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Solomon Islands | Other | 1 | $6K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 153 2025-Q4 Flucloxacillin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/flucloxacillin
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 153 2025-Q4 flucloxacillin shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian flucloxacillin shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
153
across all regions
TOTAL USD
$4.52M
2025-Q4 FOB value
UNITS
52.5M
tablets, capsules, etc.
SUPPLIERS
32
Indian exporters
BUYERS
27
global importers
COUNTRIES
25
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $391K (8.6%), spanning 11 countries.
32 Indian suppliers shipped to 27 buyers across 25 countries — average shipment value $30K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
11 countries · 38 shipments · $391K · 19 Indian suppliers · 14 buyers
SHIPMENTS
38
USD
$391K
COUNTRIES
11
SUPPLIERS
19
BUYERS
14
HHI
1,480
competitive
Top 11 destination countries in Africa
1
Kenya (44.7%)
$175K
2
South Africa (30.2%)
$118K
3
Ghana (16.8%)
$66K
4
Gambia (2.6%)
$10K
5
Burundi (2.4%)
$10K
6
Mozambique (2.2%)
$8K
7
Mauritius (0.5%)
$2K
8
Sierra Leone (0.3%)
$1K
9
Malawi (0.3%)
$1K
10
Angola (0.1%)
$200.46
11
Lesotho (0.0%)
$47.79
Top 19 Indian suppliers into Africa
1
KOPRAN LTD
$85K
2
INNOVA CAPTAB LTD
$75K
3
NIMESH PHARMA
$65K
4
LAXMI PHARMACEUTICALS PVT LTD
$52K
5
SPARSH BIO-TECH PVT LTD
$37K
6
MEDREICH LTD
$32K
7
SCOTT EDIL PHARMACIA LTD
$11K
8
GIRISH ENTERPRISES
$10K
9
MEDOPHARM PVT LTD
$10K
10
BIOMATRIX HEALTHCARE PVT LTD
$8K
11
SWISS PARENTERALS LTD
$2K
12
GIANT INTERNATIONAL PVT LTD
$1K
13
ACOMA INTERNATIONAL PVT LTD
$919.22
14
SARTHI PHARMA
$868.00
15
ZIRCON MEDTECH
$620.89
16
AURA PHARMACEUTICALS PVT LTD
$200.46
17
FINA HEALTHCARE PVT LTD
$149.85
18
MEDI SCHWALL PHARMA PVT LTD
$47.79
19
MILAN LABORATORIES (INDIA) PVT LTD
$0.0000
Top 12 Africa importers
1
CROWN SOLUTIONS LTD · Kenya
$75K
2
CROWN HEALTHCARE · Kenya
$52K
3
SANDOZSA(PTY)LTD · South Africa
$32K
4
SPARSH BIO-TECH HEALTHCARE PRIVATE · Kenya
$31K
5
LOTUS PHARMA · Burundi
$10K
6
ACE HEALTH CARE LDA · Mozambique
$8K
7
PHARMA STAR · Gambia
$5K
8
STATE BANK OF MAURITIUS · Mauritius
$2K
9
CONTINENTAL PHARMACEUTICALS LTD · Malawi
$919.22
10
T. CHOITHRAM & SONS · Sierra Leone
$825.35
11
TOTHE ORDER SHARJAH UNITED ARAB EMI · Angola
$200.46
12
QUADRI MEDICAL PTY LTD · Lesotho
$47.79
Top 5 dosage forms
1
Capsule
$266K
2
Injection
$57K
3
Solution
$57K
4
Suspension
$10K
5
Tablet
$47.79
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 11 | $112K | $10K |
| Nov | 14 | $95K | $7K |
| Dec | 13 | $184K | $14K |
Shipment register · 38 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — KOPRAN LTD · 6 shipments · $85K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | South Africa | Capsule | 39 | THD | $10.38 | $409.34 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 2 | Dec 2025 | UNLISTED BUYER | South Africa | Capsule | 275 | THD | $5.98 | $2K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 3 | Dec 2025 | UNLISTED BUYER | South Africa | Capsule | 1 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 4 | Dec 2025 | UNLISTED BUYER | South Africa | Capsule | 1 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 5 | Dec 2025 | UNLISTED BUYER | South Africa | Capsule | 156 | THD | $533.31 | $83K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 6 | Dec 2025 | UNLISTED BUYER | South Africa | Capsule | 1 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| SUPPLIER #2 — INNOVA CAPTAB LTD · 4 shipments · $75K | |||||||||||
| 7 | Oct 2025 | CROWN SOLUTIONS LTD | Kenya | Capsule | 5.0K | NOS | $3.76 | $19K | CHAWAPAYAL ICD | MOMBASA | ICD |
| 8 | Oct 2025 | CROWN SOLUTIONS LTD | Kenya | Capsule | 5.0K | NOS | $3.76 | $19K | CHAWAPAYAL ICD | MOMBASA | ICD |
| 9 | Oct 2025 | CROWN SOLUTIONS LTD | Kenya | Capsule | 4.9K | NOS | $3.76 | $19K | CHAWAPAYAL ICD | MOMBASA | ICD |
| 10 | Oct 2025 | CROWN SOLUTIONS LTD | Kenya | Capsule | 4.9K | NOS | $3.76 | $19K | CHAWAPAYAL ICD | MOMBASA | ICD |
| SUPPLIER #3 — NIMESH PHARMA · 3 shipments · $65K | |||||||||||
| 11 | Dec 2025 | UNLISTED BUYER | Ghana | Suspension | 10.0K | NOS | $0.694 | $7K | NHAVA SHEVA SEA (JNPT) | Tema | SEA |
| 12 | Dec 2025 | UNLISTED BUYER | Ghana | Capsule | 2.5K | NOS | $11.11 | $28K | NHAVA SHEVA SEA (JNPT) | Tema | SEA |
| 13 | Dec 2025 | UNLISTED BUYER | Ghana | Capsule | 15.0K | NOS | $2.02 | $30K | NHAVA SHEVA SEA (JNPT) | Tema | SEA |
| SUPPLIER #4 — LAXMI PHARMACEUTICALS PVT LTD · 2 shipments · $52K | |||||||||||
| 14 | Nov 2025 | CROWN HEALTHCARE | Kenya | Injection | 201.0K | PCS | $0.130 | $26K | NHAVA SHEVA SEA (JNPT) | Nairobi | SEA |
| 15 | Nov 2025 | CROWN HEALTHCARE | Kenya | Injection | 201.0K | PCS | $0.130 | $26K | NHAVA SHEVA SEA (JNPT) | Nairobi | SEA |
| SUPPLIER #5 — SPARSH BIO-TECH PVT LTD · 4 shipments · $37K | |||||||||||
| 16 | Oct 2025 | SPARSH BIO-TECH HEALTHCARE PRIVATE | Kenya | Solution | 591 | KGS | $20.81 | $12K | MUNDRA SEA | Mombasa | SEA |
| 17 | Oct 2025 | SPARSH BIO-TECH HEALTHCARE PRIVATE | Kenya | Solution | 591 | KGS | $20.81 | $12K | MUNDRA SEA | MOMBASA | SEA |
| 18 | Nov 2025 | SPARSH BIO-TECH HEALTHCARE PRIVATE | Kenya | Solution | 296 | KGS | $20.96 | $6K | MUNDRA SEA | Mombasa | SEA |
| 19 | Nov 2025 | UNKNOWN BUYER | Kenya | Solution | 296 | KGS | $20.96 | $6K | MUNDRA SEA | Mombasa | SEA |
| SUPPLIER #6 — MEDREICH LTD · 1 shipments · $32K | |||||||||||
| 20 | Dec 2025 | SANDOZSA(PTY)LTD | South Africa | Capsule | 852.2K | NOS | $0.037 | $32K | BANGALORE AIR | JOHANNESBURG - JOHAN | AIR |
| SUPPLIER #7 — SCOTT EDIL PHARMACIA LTD · 1 shipments · $11K | |||||||||||
| 21 | Oct 2025 | UNLISTED BUYER | Kenya | Solution | 30 | THD | $357.54 | $11K | MUNDRA SEA | Mombasa | SEA |
| SUPPLIER #8 — GIRISH ENTERPRISES · 2 shipments · $10K | |||||||||||
| 22 | Nov 2025 | PHARMA STAR | Gambia | Capsule | 3.6K | NOS | $1.40 | $5K | NHAVA SHEVA SEA (JNPT) | Banjul | SEA |
| 23 | Nov 2025 | UNKNOWN BUYER | Gambia | Capsule | 3.6K | NOS | $1.40 | $5K | NHAVA SHEVA SEA (JNPT) | Banjul | SEA |
| SUPPLIER #9 — MEDOPHARM PVT LTD · 2 shipments · $10K | |||||||||||
| 24 | Nov 2025 | LOTUS PHARMA | Burundi | Capsule | 11.4K | NOS | $0.559 | $6K | CHENNAI SEA | Bujumbura | SEA |
| 25 | Nov 2025 | LOTUS PHARMA | Burundi | Suspension | 2.9K | NOS | $1.10 | $3K | CHENNAI SEA | Bujumbura | SEA |
| SUPPLIER #10 — BIOMATRIX HEALTHCARE PVT LTD · 1 shipments · $8K | |||||||||||
| 26 | Nov 2025 | ACE HEALTH CARE LDA | Mozambique | Solution | 10.0K | NOS | $0.841 | $8K | AHMEDABAD ICD | MAPUTO | ICD |
| SUPPLIER #11 — SWISS PARENTERALS LTD · 2 shipments · $2K | |||||||||||
| 27 | Oct 2025 | STATE BANK OF MAURITIUS | Mauritius | Injection | 7.5K | NOS | $0.124 | $927.11 | AHMEDABAD AIR | MAURITIUS | AIR |
| 28 | Oct 2025 | STATE BANK OF MAURITIUS | Mauritius | Injection | 7.5K | NOS | $0.124 | $927.11 | AHMEDABAD AIR | MAURITIUS | AIR |
| SUPPLIER #12 — GIANT INTERNATIONAL PVT LTD · 3 shipments · $1K | |||||||||||
| 29 | Nov 2025 | T. CHOITHRAM & SONS | Sierra Leone | Injection | 208 | PCS | $1.98 | $410.90 | NHAVA SHEVA SEA (JNPT) | Freetown | SEA |
| 30 | Nov 2025 | T. CHOITHRAM & SONS | Sierra Leone | Injection | 208 | PCS | $1.99 | $414.45 | NHAVA SHEVA SEA (JNPT) | Freetown | SEA |
| 31 | Nov 2025 | UNKNOWN BUYER | Sierra Leone | Injection | 208 | PCS | $1.99 | $414.45 | NHAVA SHEVA SEA (JNPT) | Freetown | SEA |
| SUPPLIER #13 — ACOMA INTERNATIONAL PVT LTD · 1 shipments · $919.22 | |||||||||||
| 32 | Nov 2025 | CONTINENTAL PHARMACEUTICALS LTD | Malawi | Injection | 3.0K | NOS | $0.306 | $919.22 | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| SUPPLIER #14 — SARTHI PHARMA · 1 shipments · $868.00 | |||||||||||
| 33 | Dec 2025 | UNLISTED BUYER | South Africa | Solution | 2.0K | NOS | $0.434 | $868.00 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| SUPPLIER #15 — ZIRCON MEDTECH · 1 shipments · $620.89 | |||||||||||
| 34 | Dec 2025 | UNLISTED BUYER | Ghana | Injection | 1.0K | NOS | $0.621 | $620.89 | AHMEDABAD AIR | ACCRA | AIR |
| SUPPLIER #16 — AURA PHARMACEUTICALS PVT LTD · 1 shipments · $200.46 | |||||||||||
| 35 | Oct 2025 | TOTHE ORDER SHARJAH UNITED ARAB EMI | Angola | Injection | 100 | NOS | $2.00 | $200.46 | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| SUPPLIER #17 — FINA HEALTHCARE PVT LTD · 1 shipments · $149.85 | |||||||||||
| 36 | Nov 2025 | UNKNOWN BUYER | Malawi | Injection | 200 | NOS | $0.749 | $149.85 | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| SUPPLIER #18 — MEDI SCHWALL PHARMA PVT LTD · 1 shipments · $47.79 | |||||||||||
| 37 | Oct 2025 | QUADRI MEDICAL PTY LTD | Lesotho | Tablet | 1.0K | NOS | $0.048 | $47.79 | NHAVA SHEVA SEA (JNPT) | Maseru | SEA |
| SUPPLIER #19 — MILAN LABORATORIES (INDIA) PVT LTD · 1 shipments · $0.0000 | |||||||||||
| 38 | Dec 2025 | UNLISTED BUYER | South Africa | Capsule | 0 | THD | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
3 countries · 4 shipments · $8K · 3 Indian suppliers · 2 buyers
SHIPMENTS
4
USD
$8K
COUNTRIES
3
SUPPLIERS
3
BUYERS
2
HHI
9,244
concentrated
Top 3 destination countries in Asia
1
Myanmar (96.1%)
$8K
2
United Arab Emirates (3.2%)
$274.36
3
Saudi Arabia (0.7%)
$56.13
Top 3 Indian suppliers into Asia
1
SCOTT EDIL PHARMACIA LTD
$8K
2
SEATRACK INTERNATIONAL TRADEX PVT LTD
$274.36
3
SPECIALITY MEDICINES LTD
$56.13
Top 1 Asia importers
1
ZMC EXPRESS CARGO FZCO · United Arab Emirates
$274.36
Top 2 dosage forms
1
Injection
$6K
2
Capsule
$2K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 4 | $8K | $2K |
Shipment register · 4 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — SCOTT EDIL PHARMACIA LTD · 2 shipments · $8K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Myanmar | Capsule | 50 | THD | $34.88 | $2K | NHAVA SHEVA SEA (JNPT) | Yangon | SEA |
| 2 | Dec 2025 | UNLISTED BUYER | Myanmar | Injection | 14.0K | NOS | $0.455 | $6K | NHAVA SHEVA SEA (JNPT) | Yangon | SEA |
| SUPPLIER #2 — SEATRACK INTERNATIONAL TRADEX PVT LTD · 1 shipments · $274.36 | |||||||||||
| 3 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Capsule | 10 | NOS | $27.44 | $274.36 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #3 — SPECIALITY MEDICINES LTD · 1 shipments · $56.13 | |||||||||||
| 4 | Dec 2025 | UNLISTED BUYER | Saudi Arabia | Capsule | 5 | SET | $11.23 | $56.13 | MUMBAI AIR (SAHAR) | RIYADH | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
5 countries · 71 shipments · $3.37M · 5 Indian suppliers · 7 buyers
SHIPMENTS
71
USD
$3.37M
COUNTRIES
5
SUPPLIERS
5
BUYERS
7
HHI
3,722
concentrated
Top 5 destination countries in Europe
1
United Kingdom (69.2%)
$2.33M
2
Sweden (21.7%)
$730K
3
Netherlands (4.1%)
$139K
4
Finland (2.5%)
$85K
5
France (2.5%)
$84K
Top 5 Indian suppliers into Europe
1
MICRO LABS LTD
$1.80M
2
CADILA PHARMACEUTICALS LTD
$730K
3
MEDREICH LTD
$676K
4
AUROBINDO PHARMA LTD
$85K
5
AJANTA PHARMA LTD
$84K
Top 6 Europe importers
1
BROWN AND BURK UK LTD · United Kingdom
$1.64M
2
EQL PHARMA · Sweden
$730K
3
MEDREICH PLC · United Kingdom
$538K
4
MYLAN IRELAND LTD · Netherlands
$139K
5
ORION CORP · Finland
$85K
6
PLANET PHARMA SA · France
$84K
Top 4 dosage forms
1
Capsule
$2.37M
2
Tablet
$954K
3
Solution
$32K
4
Syrup
$11K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 35 | $1.31M | $37K |
| Nov | 24 | $1.41M | $59K |
| Dec | 12 | $659K | $55K |
Shipment register · 71 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MICRO LABS LTD · 40 shipments · $1.80M | |||||||||||
| 1 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.063 | $78K | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 2 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.219 | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 3 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 280.4K | NOS | $0.063 | $18K | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 4 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 976.9K | NOS | $0.063 | $61K | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 5 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.220 | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 6 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.220 | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 7 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.063 | $79K | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 8 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.063 | $78K | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 9 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.219 | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 10 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.063 | $79K | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 11 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.221 | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 12 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.063 | $79K | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 13 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.221 | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 14 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.063 | $79K | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 15 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.221 | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 16 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.062 | $78K | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 17 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.219 | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 18 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.062 | $78K | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 19 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.219 | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 20 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.062 | $78K | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 21 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.218 | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 22 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.062 | $78K | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 23 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.219 | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 24 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.062 | $78K | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 25 | Oct 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.219 | ENNORE SEA | LONDON GATWAY PORT | SEA |
| 26 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.062 | $78K | KAMARAJAR PORT SEA | LONDON GATWAY PORT | SEA |
| 27 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.218 | KAMARAJAR PORT SEA | LONDON GATWAY PORT | SEA |
| 28 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.062 | $78K | KAMARAJAR PORT SEA | LONDON GATWAY PORT | SEA |
| 29 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.219 | KAMARAJAR PORT SEA | LONDON GATWAY PORT | SEA |
| 30 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.062 | $78K | KAMARAJAR PORT SEA | LONDON GATWAY PORT | SEA |
| 31 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.219 | KAMARAJAR PORT SEA | LONDON GATWAY PORT | SEA |
| 32 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.062 | $78K | KAMARAJAR PORT SEA | LONDON GATWAY PORT | SEA |
| 33 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.7K | NOS | $0.0001 | $0.218 | KAMARAJAR PORT SEA | LONDON GATWAY PORT | SEA |
| 34 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.062 | $78K | HOSUR ICD | LONDON GATWAY PORT | ICD |
| 35 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.062 | $78K | HOSUR ICD | LONDON GATWAY PORT | ICD |
| 36 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.062 | $78K | HOSUR ICD | LONDON GATWAY PORT | ICD |
| 37 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.061 | $77K | KAMARAJAR PORT SEA | LONDON GATWAY PORT | SEA |
| 38 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Capsule | 1.3M | NOS | $0.061 | $77K | KAMARAJAR PORT SEA | LONDON GATWAY PORT | SEA |
| 39 | Nov 2025 | UNKNOWN BUYER | United Kingdom | Capsule | 1.3M | NOS | $0.061 | $77K | KAMARAJAR PORT SEA | LONDON GATWAY PORT | SEA |
| 40 | Nov 2025 | UNKNOWN BUYER | United Kingdom | Capsule | 1.3M | NOS | $0.061 | $77K | KAMARAJAR PORT SEA | LONDON GATWAY PORT | SEA |
| SUPPLIER #2 — CADILA PHARMACEUTICALS LTD · 10 shipments · $730K | |||||||||||
| 41 | Oct 2025 | EQL PHARMA | Sweden | Tablet | 85.3K | NOS | $0.180 | $15K | MUNDRA SEA | GOTHENBURG | SEA |
| 42 | Oct 2025 | EQL PHARMA | Sweden | Tablet | 264.6K | NOS | $0.324 | $86K | MUNDRA SEA | GOTHENBURG | SEA |
| 43 | Oct 2025 | EQL PHARMA | Sweden | Tablet | 254.6K | NOS | $0.240 | $61K | MUNDRA SEA | GOTHENBURG | SEA |
| 44 | Oct 2025 | EQL PHARMA | Sweden | Tablet | 97.2K | NOS | $0.186 | $18K | MUNDRA SEA | GOTHENBURG | SEA |
| 45 | Oct 2025 | EQL PHARMA | Sweden | Tablet | 280.9K | NOS | $0.280 | $79K | AHMEDABAD AIR | STOCKHOLM | AIR |
| 46 | Nov 2025 | EQL PHARMA | Sweden | Tablet | 286.1K | NOS | $0.233 | $67K | MUNDRA SEA | Gothenburg | SEA |
| 47 | Nov 2025 | EQL PHARMA | Sweden | Tablet | 565.6K | NOS | $0.267 | $151K | MUNDRA SEA | Gothenburg | SEA |
| 48 | Nov 2025 | EQL PHARMA | Sweden | Tablet | 286.1K | NOS | $0.233 | $67K | MUNDRA SEA | Gothenburg | SEA |
| 49 | Dec 2025 | EQL PHARMA | Sweden | Tablet | 285.2K | NOS | $0.327 | $93K | MUNDRA SEA | Gothenburg | SEA |
| 50 | Dec 2025 | EQL PHARMA | Sweden | Tablet | 286.6K | NOS | $0.327 | $94K | MUNDRA SEA | Gothenburg | SEA |
| SUPPLIER #3 — MEDREICH LTD · 12 shipments · $676K | |||||||||||
| 51 | Oct 2025 | MYLAN IRELAND LTD | Netherlands | Tablet | 435.4K | NOS | $0.081 | $35K | BANGALORE AIR | AMSTERDAM, SCHIPHOL | AIR |
| 52 | Oct 2025 | MYLAN IRELAND LTD | Netherlands | Tablet | 381.3K | NOS | $0.082 | $31K | BANGALORE AIR | AMSTERDAM, SCHIPHOL | AIR |
| 53 | Oct 2025 | MYLAN IRELAND LTD | Netherlands | Tablet | 51.3K | NOS | $0.083 | $4K | BANGALORE AIR | AMSTERDAM, SCHIPHOL | AIR |
| 54 | Nov 2025 | MEDREICH PLC | United Kingdom | Capsule | 2.7M | NOS | $0.054 | $143K | BANGALORE ICD | LONDON GATWAY PORT | ICD |
| 55 | Nov 2025 | MEDREICH PLC | United Kingdom | Capsule | 328.4K | NOS | $0.054 | $18K | BANGALORE ICD | LONDON GATWAY PORT | ICD |
| 56 | Nov 2025 | MEDREICH PLC | United Kingdom | Capsule | 1.5M | NOS | $0.054 | $78K | BANGALORE ICD | LONDON GATWAY PORT | ICD |
| 57 | Dec 2025 | MYLAN IRELAND LTD | Netherlands | Tablet | 149.0K | NOS | $0.122 | $18K | BANGALORE ICD | ROTTERDAM | ICD |
| 58 | Dec 2025 | MYLAN IRELAND LTD | Netherlands | Tablet | 194.0K | NOS | $0.122 | $24K | BANGALORE ICD | ROTTERDAM | ICD |
| 59 | Dec 2025 | MYLAN IRELAND LTD | Netherlands | Tablet | 46.8K | NOS | $0.124 | $6K | BANGALORE ICD | ROTTERDAM | ICD |
| 60 | Dec 2025 | MYLAN IRELAND LTD | Netherlands | Tablet | 149.3K | NOS | $0.137 | $20K | BANGALORE ICD | ROTTERDAM | ICD |
| 61 | Dec 2025 | MEDREICH PLC | United Kingdom | Capsule | 888.8K | NOS | $0.056 | $50K | BANGALORE ICD | LONDON GATWAY PORT | ICD |
| 62 | Dec 2025 | MEDREICH PLC | United Kingdom | Capsule | 4.5M | NOS | $0.056 | $249K | BANGALORE ICD | LONDON GATWAY PORT | ICD |
| SUPPLIER #4 — AUROBINDO PHARMA LTD · 2 shipments · $85K | |||||||||||
| 63 | Dec 2025 | ORION CORP | Finland | Tablet | 398.2K | NOS | $0.151 | $60K | HYDERABAD ICD | HELSINKI (HELSINGFOR | ICD |
| 64 | Dec 2025 | ORION CORP | Finland | Tablet | 148.5K | NOS | $0.169 | $25K | HYDERABAD ICD | HELSINKI (HELSINGFOR | ICD |
| SUPPLIER #5 — AJANTA PHARMA LTD · 7 shipments · $84K | |||||||||||
| 65 | Oct 2025 | PLANET PHARMA SA | France | Solution | 7.8K | NOS | $2.55 | $20K | NHAVA SHEVA SEA (JNPT) | Le Havre | SEA |
| 66 | Oct 2025 | PLANET PHARMA SA | France | Capsule | 5.8K | NOS | $2.42 | $14K | NHAVA SHEVA SEA (JNPT) | Le Havre | SEA |
| 67 | Nov 2025 | PLANET PHARMA SA | France | Capsule | 3.1K | NOS | $2.32 | $7K | NHAVA SHEVA SEA (JNPT) | Le Havre | SEA |
| 68 | Nov 2025 | PLANET PHARMA SA | France | Solution | 4.9K | NOS | $2.53 | $12K | NHAVA SHEVA SEA (JNPT) | Le Havre | SEA |
| 69 | Nov 2025 | PLANET PHARMA SA | France | Syrup | 4.7K | NOS | $2.30 | $11K | MUMBAI AIR (SAHAR) | PARIS | AIR |
| 70 | Dec 2025 | PLANET PHARMA SA | France | Capsule | 8.0K | NOS | $0.024 | $192.87 | NHAVA SHEVA SEA (JNPT) | Le Havre | SEA |
| 71 | Dec 2025 | PLANET PHARMA SA | France | Capsule | 8.0K | NOS | $2.40 | $19K | NHAVA SHEVA SEA (JNPT) | Le Havre | SEA |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
6 countries · 40 shipments · $749K · 9 Indian suppliers · 8 buyers
SHIPMENTS
40
USD
$749K
COUNTRIES
6
SUPPLIERS
9
BUYERS
8
HHI
4,674
concentrated
Top 6 destination countries in Oceania
1
New Zealand (40.5%)
$304K
2
Papua New Guinea (33.9%)
$254K
3
Australia (24.4%)
$183K
4
Solomon Islands (0.8%)
$6K
5
Tonga (0.3%)
$3K
6
Nauru (0.1%)
$410.18
Top 9 Indian suppliers into Oceania
1
MEDREICH LTD
$486K
2
MAXMED LIFE SCIENCES PVT LTD
$137K
3
SPARSH BIO-TECH PVT LTD
$73K
4
ARIHANT EXPORTERS
$39K
5
FINDLIFE PHARMACEUTICAL
$9K
6
WHITE LOTUS HEALTHCARE
$3K
7
LEVINS PHARMADEALS INTERNATIONAL (OPC) PRIVATE LI
$2K
8
HLL LIFECARE LTD
$410.18
9
KAMAL INTERNATIONAL DIVISION OF GAJHAM EXPORTS PRI
$1.23
Top 6 Oceania importers
1
VIATRIS NEW ZEALAND · New Zealand
$214K
2
MYLAN AUSTRALIA PTY LTD · Australia
$122K
3
SESAGO HEALTH CARE LTD · Papua New Guinea
$39K
4
GANNET PHARMA LTD · Papua New Guinea
$979.41
5
INDENT & PHARMACEUTICALS · Papua New Guinea
$878.84
6
REPUBLIC OF NAURU - DEPARTMENT OF H · Nauru
$410.18
Top 5 dosage forms
1
Capsule
$718K
2
Injection
$24K
3
Other
$3K
4
Suspension
$3K
5
Solution
$2K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 5 | $90K | $18K |
| Nov | 11 | $421K | $38K |
| Dec | 24 | $238K | $10K |
Shipment register · 40 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MEDREICH LTD · 8 shipments · $486K | |||||||||||
| 1 | Nov 2025 | VIATRIS NEW ZEALAND | New Zealand | Capsule | 917.0K | NOS | $0.066 | $60K | BANGALORE ICD | Auckland | ICD |
| 2 | Nov 2025 | VIATRIS NEW ZEALAND | New Zealand | Capsule | 452.0K | NOS | $0.066 | $30K | BANGALORE ICD | Auckland | ICD |
| 3 | Nov 2025 | UNKNOWN BUYER | New Zealand | Capsule | 917.0K | NOS | $0.066 | $60K | BANGALORE ICD | Auckland | ICD |
| 4 | Nov 2025 | UNKNOWN BUYER | New Zealand | Capsule | 452.0K | NOS | $0.066 | $30K | BANGALORE ICD | Auckland | ICD |
| 5 | Nov 2025 | MYLAN AUSTRALIA PTY LTD | Australia | Capsule | 924.2K | NOS | $0.065 | $60K | BANGALORE ICD | Brisbane | ICD |
| 6 | Nov 2025 | UNKNOWN BUYER | Australia | Capsule | 924.2K | NOS | $0.065 | $60K | BANGALORE ICD | Brisbane | ICD |
| 7 | Dec 2025 | VIATRIS NEW ZEALAND | New Zealand | Capsule | 1.8M | NOS | $0.068 | $124K | BANGALORE ICD | AUCKLAND | ICD |
| 8 | Dec 2025 | MYLAN AUSTRALIA PTY LTD | Australia | Capsule | 921.9K | NOS | $0.067 | $62K | BANGALORE ICD | BRISBANE | ICD |
| SUPPLIER #2 — MAXMED LIFE SCIENCES PVT LTD · 7 shipments · $137K | |||||||||||
| 9 | Nov 2025 | UNLISTED BUYER | Papua New Guinea | Capsule | 6.5K | NOS | $4.62 | $30K | DELHI AIR | PORT MORESBY | AIR |
| 10 | Nov 2025 | UNLISTED BUYER | Papua New Guinea | Capsule | 6.5K | NOS | $4.62 | $30K | DELHI AIR | PORT MORESBY | AIR |
| 11 | Nov 2025 | UNKNOWN BUYER | Papua New Guinea | Capsule | 6.5K | NOS | $4.62 | $30K | DELHI AIR | PORT MORESBY | AIR |
| 12 | Nov 2025 | UNKNOWN BUYER | Papua New Guinea | Capsule | 6.5K | NOS | $4.62 | $30K | DELHI AIR | PORT MORESBY | AIR |
| 13 | Dec 2025 | UNLISTED BUYER | Papua New Guinea | Capsule | 3.0K | NOS | $2.40 | $7K | DELHI AIR | PORT MORESBY | AIR |
| 14 | Dec 2025 | UNLISTED BUYER | Papua New Guinea | Capsule | 3.0K | NOS | $2.40 | $7K | DELHI AIR | PORT MORESBY | AIR |
| 15 | Dec 2025 | UNLISTED BUYER | Papua New Guinea | Capsule | 1.0K | NOS | $2.40 | $2K | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
| SUPPLIER #3 — SPARSH BIO-TECH PVT LTD · 2 shipments · $73K | |||||||||||
| 16 | Oct 2025 | UNLISTED BUYER | Papua New Guinea | Capsule | 696 | KGS | $67.52 | $47K | MUNDRA SEA | MOTUKEA ISLAND | SEA |
| 17 | Oct 2025 | UNLISTED BUYER | Papua New Guinea | Capsule | 363 | KGS | $72.82 | $26K | MUNDRA SEA | MOTUKEA ISLAND | SEA |
| SUPPLIER #4 — ARIHANT EXPORTERS · 10 shipments · $39K | |||||||||||
| 18 | Oct 2025 | SESAGO HEALTH CARE LTD | Papua New Guinea | Capsule | 1.8K | PCS | $8.87 | $16K | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
| 19 | Dec 2025 | SESAGO HEALTH CARE LTD | Papua New Guinea | Injection | 23.2K | PCS | $0.210 | $5K | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
| 20 | Dec 2025 | SESAGO HEALTH CARE LTD | Papua New Guinea | Injection | 400 | PCS | $0.210 | $84.00 | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
| 21 | Dec 2025 | SESAGO HEALTH CARE LTD | Papua New Guinea | Injection | 24.0K | PCS | $0.260 | $6K | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
| 22 | Dec 2025 | SESAGO HEALTH CARE LTD | Papua New Guinea | Injection | 23.2K | PCS | $0.214 | $5K | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
| 23 | Dec 2025 | SESAGO HEALTH CARE LTD | Papua New Guinea | Injection | 400 | PCS | $0.214 | $85.72 | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
| 24 | Dec 2025 | SESAGO HEALTH CARE LTD | Papua New Guinea | Injection | 24.0K | PCS | $0.265 | $6K | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
| 25 | Dec 2025 | SESAGO HEALTH CARE LTD | Papua New Guinea | Injection | 23.2K | PCS | $0.0024 | $55.49 | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
| 26 | Dec 2025 | SESAGO HEALTH CARE LTD | Papua New Guinea | Injection | 400 | PCS | $0.0024 | $0.957 | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
| 27 | Dec 2025 | SESAGO HEALTH CARE LTD | Papua New Guinea | Injection | 24.0K | PCS | $0.0030 | $71.07 | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
| SUPPLIER #5 — FINDLIFE PHARMACEUTICAL · 3 shipments · $9K | |||||||||||
| 28 | Dec 2025 | UNLISTED BUYER | Solomon Islands | Solution | 2.0K | NOS | $0.982 | $2K | MUMBAI AIR (SAHAR) | HONIARA | AIR |
| 29 | Dec 2025 | UNLISTED BUYER | Solomon Islands | Capsule | 1.0K | NOS | $4.00 | $4K | MUMBAI AIR (SAHAR) | HONIARA | AIR |
| 30 | Dec 2025 | UNLISTED BUYER | Tonga | Suspension | 2.7K | NOS | $0.936 | $3K | NHAVA SHEVA SEA (JNPT) | Nuku'alofa-Tongatapu | SEA |
| SUPPLIER #6 — WHITE LOTUS HEALTHCARE · 4 shipments · $3K | |||||||||||
| 31 | Dec 2025 | UNLISTED BUYER | Papua New Guinea | Suspension | 49 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
| 32 | Dec 2025 | UNLISTED BUYER | Papua New Guinea | Suspension | 1 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
| 33 | Dec 2025 | UNLISTED BUYER | Papua New Guinea | Other | 49 | NOS | $57.11 | $3K | AHMEDABAD ICD | PORT MORESBY | ICD |
| 34 | Dec 2025 | UNLISTED BUYER | Papua New Guinea | Other | 1 | NOS | $39.72 | $39.72 | AHMEDABAD ICD | PORT MORESBY | ICD |
| SUPPLIER #7 — LEVINS PHARMADEALS INTERNATIONAL (OPC) PRIVATE LI · 3 shipments · $2K | |||||||||||
| 35 | Oct 2025 | INDENT & PHARMACEUTICALS | Papua New Guinea | Injection | 500 | PCS | $0.879 | $439.42 | TUGHLAKABAD ICD | Lae | ICD |
| 36 | Oct 2025 | INDENT & PHARMACEUTICALS | Papua New Guinea | Injection | 500 | PCS | $0.879 | $439.42 | TUGHLAKABAD ICD | Lae | ICD |
| 37 | Nov 2025 | GANNET PHARMA LTD | Papua New Guinea | Capsule | 50 | PCS | $19.59 | $979.41 | DELHI AIR | PORT MORESBY | AIR |
| SUPPLIER #8 — HLL LIFECARE LTD · 2 shipments · $410.18 | |||||||||||
| 38 | Dec 2025 | REPUBLIC OF NAURU - DEPARTMENT OF H | Nauru | Injection | 1.8K | NOS | $0.020 | $36.88 | DELHI AIR | NAURU ISLAND | AIR |
| 39 | Dec 2025 | REPUBLIC OF NAURU - DEPARTMENT OF H | Nauru | Capsule | 18.3K | NOS | $0.020 | $373.30 | DELHI AIR | NAURU ISLAND | AIR |
| SUPPLIER #9 — KAMAL INTERNATIONAL DIVISION OF GAJHAM EXPORTS PRI · 1 shipments · $1.23 | |||||||||||
| 40 | Dec 2025 | UNLISTED BUYER | Papua New Guinea | Injection | 300 | NOS | $0.0041 | $1.23 | MUMBAI AIR (SAHAR) | PORT MORESBY | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 32 Indian flucloxacillin exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped flucloxacillin in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | MICRO LABS LTD | BANGALORE | 40 | $1.80M | Capsule | Europe |
| 2 | MEDREICH LTD | BENGALURU | 21 | $1.19M | Tablet, Capsule | Europe, Oceania |
| 3 | CADILA PHARMACEUTICALS LTD | AHMEDABAD | 10 | $730K | Tablet | Europe |
| 4 | MAXMED LIFE SCIENCES PVT LTD | RUDRAPUR | 7 | $137K | Capsule | Oceania |
| 5 | SPARSH BIO-TECH PVT LTD | JAMNAGAR | 6 | $110K | Capsule, Solution | Oceania, Africa |
| 6 | KOPRAN LTD | WORLI | 6 | $85K | Capsule | Africa |
| 7 | AUROBINDO PHARMA LTD | MEDCHAL | 2 | $85K | Tablet | Europe |
| 8 | AJANTA PHARMA LTD | MUMBAI. | 7 | $84K | Solution, Capsule, Syrup | Europe |
| 9 | INNOVA CAPTAB LTD | BADDI | 4 | $75K | Capsule | Africa |
| 10 | NIMESH PHARMA | VADODARA | 3 | $65K | Suspension, Capsule | Africa |
| 11 | LAXMI PHARMACEUTICALS PVT LTD | NAVI MUMBAI (MAHARASHTRA) | 2 | $52K | Injection | Africa |
| 12 | ARIHANT EXPORTERS | SURENDRANAGAR/GUJARAT | 10 | $39K | Capsule, Injection | Oceania |
| 13 | SCOTT EDIL PHARMACIA LTD | BADDI | 3 | $19K | Solution, Capsule, Injection | Africa, Asia |
| 14 | GIRISH ENTERPRISES | KOTA | 2 | $10K | Capsule | Africa |
| 15 | MEDOPHARM PVT LTD | CHENNAI TAMILNADU | 2 | $10K | Capsule, Suspension | Africa |
| 16 | FINDLIFE PHARMACEUTICAL | SURAT | 3 | $9K | Solution, Capsule, Suspension | Oceania |
| 17 | BIOMATRIX HEALTHCARE PVT LTD | AHMADABAD | 1 | $8K | Solution | Africa |
| 18 | WHITE LOTUS HEALTHCARE | SURAT | 4 | $3K | Suspension, Other | Oceania |
| 19 | LEVINS PHARMADEALS INTERNATIONAL (OPC) PRIVATE LI | KARNAL | 3 | $2K | Injection, Capsule | Oceania |
| 20 | SWISS PARENTERALS LTD | AHMEDABAD | 2 | $2K | Injection | Africa |
| 21 | GIANT INTERNATIONAL PVT LTD | JAIPUR | 3 | $1K | Injection | Africa |
| 22 | ACOMA INTERNATIONAL PVT LTD | Surat | 1 | $919.22 | Injection | Africa |
| 23 | SARTHI PHARMA | RAJKOT | 1 | $868.00 | Solution | Africa |
| 24 | ZIRCON MEDTECH | VADODARA | 1 | $620.89 | Injection | Africa |
| 25 | HLL LIFECARE LTD | UTTAR PRADESH | 2 | $410.18 | Injection, Capsule | Oceania |
| 26 | SEATRACK INTERNATIONAL TRADEX PVT LTD | NEW DELHI | 1 | $274.36 | Capsule | Asia |
| 27 | AURA PHARMACEUTICALS PVT LTD | MUMBAI M S | 1 | $200.46 | Injection | Africa |
| 28 | FINA HEALTHCARE PVT LTD | Ramnimi Casawaji Patel Road | 1 | $149.85 | Injection | Africa |
| 29 | SPECIALITY MEDICINES LTD | MUMBAI | 1 | $56.13 | Capsule | Asia |
| 30 | MEDI SCHWALL PHARMA PVT LTD | AURANGABAD | 1 | $47.79 | Tablet | Africa |
| 31 | KAMAL INTERNATIONAL DIVISION OF GAJHAM EXPORTS PRI | MUMBAI | 1 | $1.23 | Injection | Oceania |
| 32 | MILAN LABORATORIES (INDIA) PVT LTD | LTD KAMOTHE PANVEL NAVI MUMBAI | 1 | $0.0000 | Capsule | Africa |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 25 global flucloxacillin importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian flucloxacillin in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | BROWN AND BURK UK LTD | United Kingdom | 38 | $1.64M | MICRO LABS LTD | Capsule |
| 2 | EQL PHARMA | Sweden | 10 | $730K | CADILA PHARMACEUTICA… | Tablet |
| 3 | MEDREICH PLC | United Kingdom | 5 | $538K | MEDREICH LTD | Capsule |
| 4 | VIATRIS NEW ZEALAND | New Zealand | 3 | $214K | MEDREICH LTD | Capsule |
| 5 | MYLAN IRELAND LTD | Netherlands | 7 | $139K | MEDREICH LTD | Tablet |
| 6 | MYLAN AUSTRALIA PTY LTD | Australia | 2 | $122K | MEDREICH LTD | Capsule |
| 7 | ORION CORP | Finland | 2 | $85K | AUROBINDO PHARMA LTD | Tablet |
| 8 | PLANET PHARMA SA | France | 7 | $84K | AJANTA PHARMA LTD | Solution, Capsule, Syrup |
| 9 | CROWN SOLUTIONS LTD | Kenya | 4 | $75K | INNOVA CAPTAB LTD | Capsule |
| 10 | CROWN HEALTHCARE | Kenya | 2 | $52K | LAXMI PHARMACEUTICAL… | Injection |
| 11 | SESAGO HEALTH CARE LTD | Papua New Guinea | 10 | $39K | ARIHANT EXPORTERS | Capsule, Injection |
| 12 | SANDOZSA(PTY)LTD | South Africa | 1 | $32K | MEDREICH LTD | Capsule |
| 13 | SPARSH BIO-TECH HEALTHCARE PRIVATE | Kenya | 3 | $31K | SPARSH BIO-TECH PVT … | Solution |
| 14 | LOTUS PHARMA | Burundi | 2 | $10K | MEDOPHARM PVT LTD | Capsule, Suspension |
| 15 | ACE HEALTH CARE LDA | Mozambique | 1 | $8K | BIOMATRIX HEALTHCARE… | Solution |
| 16 | PHARMA STAR | Gambia | 1 | $5K | GIRISH ENTERPRISES | Capsule |
| 17 | STATE BANK OF MAURITIUS | Mauritius | 2 | $2K | SWISS PARENTERALS LTD | Injection |
| 18 | GANNET PHARMA LTD | Papua New Guinea | 1 | $979.41 | LEVINS PHARMADEALS I… | Capsule |
| 19 | CONTINENTAL PHARMACEUTICALS LTD | Malawi | 1 | $919.22 | ACOMA INTERNATIONAL … | Injection |
| 20 | INDENT & PHARMACEUTICALS | Papua New Guinea | 2 | $878.84 | LEVINS PHARMADEALS I… | Injection |
| 21 | T. CHOITHRAM & SONS | Sierra Leone | 2 | $825.35 | GIANT INTERNATIONAL … | Injection |
| 22 | REPUBLIC OF NAURU - DEPARTMENT OF H | Nauru | 2 | $410.18 | HLL LIFECARE LTD | Injection, Capsule |
| 23 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | 1 | $274.36 | SEATRACK INTERNATION… | Capsule |
| 24 | TOTHE ORDER SHARJAH UNITED ARAB EMI | Angola | 1 | $200.46 | AURA PHARMACEUTICALS… | Injection |
| 25 | QUADRI MEDICAL PTY LTD | Lesotho | 1 | $47.79 | MEDI SCHWALL PHARMA … | Tablet |
This report covers 153 2025-Q4 Flucloxacillin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/flucloxacillin
Talk to our trade analyst
Need a custom flucloxacillin report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/flucloxacillin
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Flucloxacillin product page
Live data, supplier directory, price trends, and trade route analysis